These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21636616)

  • 1. The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK.
    Woodhall SC; Jit M; Soldan K; Kinghorn G; Gilson R; Nathan M; Ross JD; Lacey CJ;
    Sex Transm Infect; 2011 Oct; 87(6):458-63. PubMed ID: 21636616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of treatment and QALYs lost due to genital warts: data for the economic evaluation of HPV vaccines in the United Kingdom.
    Woodhall SC; Jit M; Cai C; Ramsey T; Zia S; Crouch S; Birks Y; Newton R; Edmunds WJ; Lacey CJ
    Sex Transm Dis; 2009 Aug; 36(8):515-21. PubMed ID: 19543143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study.
    Hillemanns P; Breugelmans JG; Gieseking F; Bénard S; Lamure E; Littlewood KJ; Petry KU
    BMC Infect Dis; 2008 Jun; 8():76. PubMed ID: 18518976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genital warts and cost of care in England.
    Desai S; Wetten S; Woodhall SC; Peters L; Hughes G; Soldan K
    Sex Transm Infect; 2011 Oct; 87(6):464-8. PubMed ID: 21813567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing incidence and economic burden of genital warts with data from a US commercially insured population.
    Hoy T; Singhal PK; Willey VJ; Insinga RP
    Curr Med Res Opin; 2009 Oct; 25(10):2343-51. PubMed ID: 19650749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of the impact of genital warts on health-related quality of life.
    Woodhall S; Ramsey T; Cai C; Crouch S; Jit M; Birks Y; Edmunds WJ; Newton R; Lacey CJ
    Sex Transm Infect; 2008 Jun; 84(3):161-6. PubMed ID: 18339658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining the cost of genital warts: a study from Ireland.
    Dee A; Howell F; O'Connor C; Cremin S; Hunter K
    Sex Transm Infect; 2009 Sep; 85(5):402-3. PubMed ID: 19004863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
    Gilson R; Nugent D; Bennett K; Doré CJ; Murray ML; Meadows J; Haddow LJ; Lacey C; Sandmann F; Jit M; Soldan K; Tetlow M; Caverly E; Nathan M; Copas AJ
    Health Technol Assess; 2020 Sep; 24(47):1-86. PubMed ID: 32975189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment patterns and associated costs for genital warts in Italy.
    Merito M; Largeron N; Cohet C; Timelli L; Boselli F; Matteelli A; Naldi L; Vittori G
    Curr Med Res Opin; 2008 Nov; 24(11):3175-83. PubMed ID: 18851777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The costs of managing genital warts in the UK by devolved nation: England, Scotland, Wales and Northern Ireland.
    Coles VA; Chapman R; Lanitis T; Carroll SM
    Int J STD AIDS; 2016 Jan; 27(1):51-7. PubMed ID: 25681263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of human papillomavirus-related genital diseases on quality of life and psychosocial wellbeing: results of an observational, health-related quality of life study in the UK.
    Dominiak-Felden G; Cohet C; Atrux-Tallau S; Gilet H; Tristram A; Fiander A
    BMC Public Health; 2013 Nov; 13():1065. PubMed ID: 24215264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of quality of life associated with genital warts: baseline analyses from a prospective study.
    Sénécal M; Brisson M; Maunsell E; Ferenczy A; Franco EL; Ratnam S; Coutlée F; Palefsky JM; Mansi JA
    Sex Transm Infect; 2011 Apr; 87(3):209-15. PubMed ID: 21335602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of genital warts on emotional and sexual well-being differs by gender.
    Vriend HJ; Nieuwkerk PT; van der Sande MA
    Int J STD AIDS; 2014 Nov; 25(13):949-55. PubMed ID: 24671715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical Care Costs Associated with Genital Warts for Commercially Insured US Patients.
    Dahlstrom KR; Fu S; Chan W; Shelal Z; Ramondetta LM; Lairson DR
    Pharmacoeconomics; 2018 Nov; 36(11):1355-1365. PubMed ID: 30019118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of anogenital warts on health-related quality of life: a 6-month prospective study.
    Drolet M; Brisson M; Maunsell E; Franco EL; Coutlée F; Ferenczy A; Ratnam S; Fisher W; Mansi JA
    Sex Transm Dis; 2011 Oct; 38(10):949-56. PubMed ID: 21934571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Condylomata acuminata (genital warts): patient demographics and treating physicians.
    Fleischer AB; Parrish CA; Glenn R; Feldman SR
    Sex Transm Dis; 2001 Nov; 28(11):643-7. PubMed ID: 11677386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quality of life of patients with condyloma].
    Mortensen GL; Larsen HK
    Ugeskr Laeger; 2008 Nov; 170(47):3858-62. PubMed ID: 19014739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The health and economic burden of genital warts in a set of private health plans in the United States.
    Insinga RP; Dasbach EJ; Myers ER
    Clin Infect Dis; 2003 Jun; 36(11):1397-403. PubMed ID: 12766834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The quality of life of patients with genital warts: a qualitative study.
    Mortensen GL; Larsen HK
    BMC Public Health; 2010 Mar; 10():113. PubMed ID: 20205944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimates.
    Ong KJ; Checchi M; Burns L; Pavitt C; Postma MJ; Jit M
    Sex Transm Infect; 2019 Feb; 95(1):28-35. PubMed ID: 30674687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.